BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Alexandrova R, Beykov P, Vassilev D, Jukić M, Podlipnik Č. The virus that shook the world: questions and answers about SARS-CoV-2 and COVID-19. Biotechnology & Biotechnological Equipment 2021;35:74-102. [DOI: 10.1080/13102818.2020.1847683] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Popov D, Hadzhiyanev A. Pituitary apoplexy associated with COVID-19 infection: review and a case report. Biotechnology & Biotechnological Equipment 2022;36:75-81. [DOI: 10.1080/13102818.2022.2051738] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Podlipnik Č, Alexandrova R, Pleško S, Bren U, Jukič M. Perspective Chapter: Bioinformatics Study of the Evolution of SARS-CoV-2 Spike Protein. Infectious Diseases 2022. [DOI: 10.5772/intechopen.105915] [Reference Citation Analysis]
3 Antonopoulou V, Goffe L, Meyer CJ, Grimani A, Graham F, Lecouturier J, Tang MY, Chadwick P, Sniehotta FF. A comparison of seasonal influenza and novel Covid-19 vaccine intentions: A cross-sectional survey of vaccine hesitant adults in England during the 2020 pandemic. Hum Vaccin Immunother 2022;:2085461. [PMID: 35816683 DOI: 10.1080/21645515.2022.2085461] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
4 Kostadinova T, Todorova T, Stoykova Z, Niyazi D, Bozhkova M, Bizheva S, Stoeva T. Dynamics of COVID-19 and demographic characteristics as predisposing risk factors for SARS-CoV-2 infection: a hospital-based, one-center retrospective study. Biotechnology & Biotechnological Equipment 2021;35:1869-73. [DOI: 10.1080/13102818.2022.2026817] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Nwagwu CS, Ugwu CN, Ogbonna JDN, Onugwu AL, Agbo CP, Echezona AC, Ezeibe EN, Uzondu S, Kenechukwu FC, Akpa PA, Momoh MA, Nnamani PO, Tarirai C, Ofokansi KC, Attama AA. Recent and advanced nano-technological strategies for COVID-19 vaccine development. Covid-19: Biomedical Perspectives 2022. [DOI: 10.1016/bs.mim.2022.03.001] [Reference Citation Analysis]
6 Vaiwala R, Ayappa KG. A Generic Force Field for Simulating Native Protein Structures Using Dissipative Particle Dynamics.. [DOI: 10.1101/2021.08.16.456428] [Reference Citation Analysis]
7 Burke PF, Masters D, Massey G. Enablers and barriers to COVID-19 vaccine uptake: An international study of perceptions and intentions. Vaccine 2021;39:5116-28. [PMID: 34340856 DOI: 10.1016/j.vaccine.2021.07.056] [Cited by in Crossref: 41] [Cited by in F6Publishing: 47] [Article Influence: 41.0] [Reference Citation Analysis]
8 Huang L, Gu M, Wang Z, Tang TW, Zhu Z, Yuan Y, Wang D, Shen C, Tang BZ, Ye R. Highly Efficient and Rapid Inactivation of Coronavirus on Non-Metal Hydrophobic Laser-Induced Graphene in Mild Conditions. Adv Funct Mater 2021;31:2101195. [PMID: 34149339 DOI: 10.1002/adfm.202101195] [Cited by in Crossref: 24] [Cited by in F6Publishing: 29] [Article Influence: 24.0] [Reference Citation Analysis]
9 El-Sayed A, Kamel M. Coronaviruses in humans and animals: the role of bats in viral evolution. Environ Sci Pollut Res Int 2021;28:19589-600. [PMID: 33655480 DOI: 10.1007/s11356-021-12553-1] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 18.0] [Reference Citation Analysis]